INDIA LIVE DESKNIFTY 50:23,140.50(+0.34%)SENSEX:73,895.74(+0.43%)
RDU Global
🇮🇳
Home/Topics/Companies & Institutions/Chinese biotech companies
Back to Newsroom
🏢Organization Dossier

Chinese biotech companies

Curated news coverage, institutional background, regulatory filings, and investigative reporting across RDU Global.

6 Stories Indexed
Last Updated: Just Now
Verified Entity Intelligence
Global Health & Biotech Just now (01:37 PM IST)

Big Pharma’s China Deal Spree Deepens as Latest Tie-Up Could Reach $7.8 Billion

Western drugmakers are accelerating their search for innovation in China as the industry braces for a wave of patent expirations that threatens future revenue. The latest deal, potentially worth up to $7.8 billion, underscores how Chinese biotech has become a critical source of early-stage assets for global pharma giants.

By RDU Global Wire5 min read
Markets, IPOs & Wealth07 Oct 2026, 01:22 PM IST

Hong Kong Stocks Slip as Oil Gains, Weak Data and Tech Selling Weigh on Sentiment

Hong Kong equities fell on Monday as higher oil prices, softer economic signals and broad selling in technology and biotechnology shares pressured the market. The Hang Seng Index lost 0.5%, while the tech gauge dropped 0.9%, even as investors continued to weigh hopes for policy support from Beijing against signs of cooling demand.

4 min readRead →
Global Health & Biotech04 Oct 2026, 08:22 AM IST

Novartis Agrees to Up to $7.8 Billion mRNA Deal With China’s Abogen

Novartis has struck a licensing and development agreement with Chinese biotech Abogen Biosciences that could be worth as much as $7.8 billion, underscoring the Swiss drugmaker’s push into next-generation cancer therapies. The deal centers on an mRNA-encoded T-cell engager, a highly targeted approach that has drawn intense interest from large pharmaceutical companies seeking to replenish pipelines and deepen exposure to innovative Chinese science.

6 min readRead →
Startups & Venture CapitalJust now (02:02 PM IST)

Beam Therapeutics Sues Chinese Biotech and VC-Backed Startup Over Alleged IP Theft

Beam Therapeutics has filed suit against a Chinese biotech company and a venture-capital-backed startup, alleging theft of intellectual property tied to its gene-editing technology, according to STAT. The case adds to mounting tensions over biotech innovation, cross-border technology transfer, and the protection of proprietary research in a sector where patents and trade secrets are central to valuation.

6 min readRead →
Healthcare, Pharma & Life SciencesJust now (09:13 AM IST)

Godavari Biorefineries Wins Chinese Patent for Viral Infection Treatment Compounds

Godavari Biorefineries has secured a Chinese patent covering compounds that inhibit Vacuolar ATPase, or V-ATPase, a cellular pathway some viruses exploit during infection. The grant strengthens the company’s intellectual-property position in a strategically important pharmaceutical market and could support future development of antiviral medicaments.

5 min readRead →
Healthcare, Pharma & Life SciencesJust now (02:37 AM IST)

Godavari Biorefineries Secures Chinese Patent for Viral Infection Treatment Compounds

Godavari Biorefineries has secured a Chinese patent covering compounds that inhibit Vacuolar ATPase, or V-ATPase, a cellular mechanism some viruses exploit during infection. The grant strengthens the company’s intellectual property position in a major pharmaceutical market and underscores the continuing commercial value of antiviral research tied to novel mechanisms of action.

4 min readRead →

🏢 About this Entity

Corporations, startups, regulatory bodies, central banks, ministries and judicial courts. All news mentioning this entity is automatically verified and aggregated into this live intelligence dossier.

Co-Occurring Entities

Entities frequently referenced alongside Chinese biotech companies: